Skip to main content
AVANOS MEDICAL, INC. logo

AVANOS MEDICAL, INC. — Investor Relations & Filings

Ticker · AVNS ISIN · US40650V1008 LEI · 549300YCXWOM7NEWMQ58 US Manufacturing
Open in API
Filings indexed 673 across all filing types
Latest filing 2021-05-10 Director's Dealing
Country US United States of America
Listing US AVNS

About AVANOS MEDICAL, INC.

https://avanos.com/

Avanos Medical, Inc. is a medical technology company that develops, manufactures, and markets medical device solutions. The company's portfolio is focused on two primary segments: Pain Management & Recovery and Enteral Feeding. The Pain Management & Recovery division provides a range of non-opioid therapies and solutions for managing chronic and post-surgical pain, targeting specialties such as anesthesiology, orthopedics, and interventional pain management. The Enteral Feeding division offers a comprehensive portfolio of nutrition delivery systems and products for a wide spectrum of patients, from neonates and pediatrics to adults, supporting healthcare providers in critical and long-term care settings. The company is focused on delivering clinically superior solutions that improve patient outcomes and facilitate recovery.

Recent filings

Filing Released Lang Actions
FORM 3
Director's Dealing
2021-05-10 English
FORM 4
Director's Dealing
2021-05-07 English
FORM 10-Q
Interim / Quarterly Report Q1 2021
2021-05-07 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 7, 2021, by Avanos Medical, Inc. It announces the results of operations for the quarter ended March 31, 2021, referencing a press release attached as Exhibit 99.1. The text explicitly states that the information is being furnished and not filed, and the actual financial results are in the press release exhibit, not in this document. The document length is 3704 characters, which is relatively short and mainly serves as an announcement of the earnings release rather than containing substantive financial data itself. According to the rules, such a document is best classified as an Earnings Release (ER) since it announces quarterly financial results, but the actual detailed financial data is in the attached press release. However, since the document itself is a Form 8-K announcing the earnings release and includes the press release as an exhibit, and the text states the information is furnished and not filed, this is a typical format for an Earnings Release filing. Therefore, the classification is Earnings Release (ER).
2021-05-07 English
FORM 4
Director's Dealing
2021-05-05 English
FORM 4
Director's Dealing
2021-05-05 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.